Series B - MabVax Therapeutics - Nov 20, 2012 Funding Round Profile - Cointime

Bitcoin $97,827.56 -0.48%
Ethereum $3,356.00 -2.00%
BNB $657.82 -0.12%
Optimism $2.15 -6.46%
Arbitrum $0.84 -5.86%
Solana $251.96 -2.42%
Polygon $0.55 -5.61%
Cosmos $8.44 -10.66%
Avalanche $40.99 -3.71%

Bitcoin $97,827.56 -0.48%
Ethereum $3,356.00 -2.00%
BNB $657.82 -0.12%
Optimism $2.15 -6.46%
Arbitrum $0.84 -5.86%
Solana $251.96 -2.42%
Polygon $0.55 -5.61%
Cosmos $8.44 -10.66%
Avalanche $40.99 -3.71%

MabVax Therapeutics

company

Funding Round

Series B

Money Raised

$ 5.25M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Numoda Capital Innovations	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Feb 27, 2008	Series A	$ 8M	GBP Capital	Detail